A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Leniolisib

Leniolisib & 其杂质

Leniolisib is a medication used to treat a genetic disorder that weakens the immune system, specifically caused by a mutation associated with activated PI3K delta syndrome (APDS). It is the first drug approved for managing this condition and has been designated by the U.S. Food and Drug Administration (FDA) as a first-in-class treatment.

SynZeal 是药用对照品领域的领先创新者。我们提供高质量的对照品 Leniolisib，药典及非药典 Leniolisib 杂质、代谢物、稳定同位素产品以及亚硝胺（N-NO 产品）。 Leniolisib 杂质对照品在药物研发中非常有用。它们在产品开发、ANDA 和 DMF 申报、质量控制（QC）、方法验证及稳定性研究中均有应用。同时，它们也用于未知杂质的识别及基因毒性潜力的评估。